1887

Abstract

Mixed cytomegalovirus (CMV) infections are associated with delayed viral clearance in solid organ transplant recipients. We investigated whether this could be extrapolated to allogeneic stem cell transplant (allo-SCT) recipients. A total of 48 plasma specimens, obtained during 29 episodes of active CMV infection in 25 non-consecutive allo-SCT patients, were analysed. Baseline blood specimens, drawn shortly prior to the inception of pre-emptive antiviral therapy (pre-treatment specimen; n=29), as well as follow-up samples obtained either after the initiation of antiviral therapy (post-treatment specimen; n=15) or during recurrent episodes (n=4) were analysed. Plasma CMV DNA loads were quantified by real-time PCR and the CMV genotyping was performed by ultra-deep sequencing of hypervariable regions in the genes coding for glycoproteins N (gN) and O (gO). A trend towards higher CMV DNA peak loads, longer CMV DNAemia episode durations and slower CMV DNAemia decay rates was observed for episodes with mixed CMV genotype populations compared to those caused by single CMV variants, although the differences did not reach statistical significance. The length of the treatment course required to clear DNAemia was significantly longer in these mixed episodes (P=0.002). Significant changes in the number or frequency of CMV gN or gO genetic variants were documented following the initiation of antiviral therapy or in recurrent episodes. CMV diversity may have a major impact on the kinetics of CMV DNAemia clearance during the treatment of active CMV infection episodes in allo-SCT recipients.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000916
2017-09-06
2019-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/10/2530.html?itemId=/content/journal/jgv/10.1099/jgv.0.000916&mimeType=html&fmt=ahah

References

  1. Dolan A, Cunningham C, Hector RD, Hassan-Walker AF, Lee L et al. Genetic content of wild-type human cytomegalovirus. J Gen Virol 2004; 85: 1301– 1312 [CrossRef] [PubMed]
    [Google Scholar]
  2. Pignatelli S, dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004; 14: 383– 410 [CrossRef] [PubMed]
    [Google Scholar]
  3. Puchhammer-Stöckl E, Görzer I. Human cytomegalovirus: an enormous variety of strains and their possible clinical significance in the human host. Future Virol 2011; 6: 259– 271 [CrossRef]
    [Google Scholar]
  4. Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog 2011; 7: e1001344 [CrossRef] [PubMed]
    [Google Scholar]
  5. Görzer I, Guelly C, Trajanoski S, Puchhammer-Stöckl E. Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J Virol 2010; 84: 7195– 7203 [CrossRef] [PubMed]
    [Google Scholar]
  6. Romero PP, Blanco P, Giménez E, Solano C, Navarro D. An update on the management and prevention of cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation. Future Virol 2015; 10: 113– 134 [CrossRef]
    [Google Scholar]
  7. Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009; 113: 5711– 5719 [CrossRef] [PubMed]
    [Google Scholar]
  8. Solano C, De La Cámara R, Vázquez L, López J, Giménez E et al. Cytomegalovirus infection management in allogeneic stem cell transplant recipients: a National Survey in Spain. J Clin Microbiol 2015; 53: 2741– 2744 [CrossRef] [PubMed]
    [Google Scholar]
  9. Tormo N, Solano C, Benet I, Clari MA, Nieto J et al. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2010; 45: 543– 549 [CrossRef] [PubMed]
    [Google Scholar]
  10. Giménez E, Solano C, Azanza JR, Amat P, Navarro D. Monitoring of trough plasma ganciclovir levels and peripheral blood cytomegalovirus (CMV)-specific CD8+ T cells to predict CMV DNAemia clearance in preemptively treated allogeneic stem cell transplant recipients. Antimicrob Agents Chemother 2014; 58: 5602– 5605 [CrossRef] [PubMed]
    [Google Scholar]
  11. Humar A, Kumar D, Gilbert C, Boivin G. Cytomegalovirus (CMV) glycoprotein B genotypes and response to antiviral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 2003; 188: 581– 584 [CrossRef] [PubMed]
    [Google Scholar]
  12. Coaquette A, Bourgeois A, Dirand C, Varin A, Chen W et al. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 2004; 39: 155– 161 [CrossRef] [PubMed]
    [Google Scholar]
  13. Manuel O, Asberg A, Pang X, Rollag H, Emery VC et al. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009; 49: 1160– 1166 [CrossRef] [PubMed]
    [Google Scholar]
  14. Kilpatrick BA, Huang ES, Pagano JS. Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol 1976; 18: 1095– 1105 [PubMed]
    [Google Scholar]
  15. Renzette N, Gibson L, Bhattacharjee B, Fisher D, Schleiss MR et al. Rapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection. PLoS Genet 2013; 9: e1003735 [CrossRef] [PubMed]
    [Google Scholar]
  16. Sijmons S, Thys K, Mbong Ngwese M, van Damme E, Dvorak J et al. High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination. J Virol 2015; 89: 7673– 7695 [CrossRef] [PubMed]
    [Google Scholar]
  17. Hage E, Wilkie GS, Linnenweber-Held S, Dhingra A, Suárez NM et al. Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole genomic sequencing directly from clinical specimens. J Infect Dis 2017; 215: 1673– 1683 [CrossRef] [PubMed]
    [Google Scholar]
  18. Wu X, Wang Y, Xu Y, Wu D, Sun A et al. Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China. Biol Blood Marrow Transplant 2010; 16: 647– 652 [CrossRef] [PubMed]
    [Google Scholar]
  19. Dieamant DC, Bonon SH, Peres RM, Costa CR, Albuquerque DM et al. Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation. BMC Infect Dis 2013; 13: 310 [CrossRef] [PubMed]
    [Google Scholar]
  20. Puchhammer-Stöckl E, Görzer I, Zoufaly A, Jaksch P, Bauer CC et al. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 2006; 81: 187– 194 [CrossRef] [PubMed]
    [Google Scholar]
  21. Smith C, Brennan RM, Tey SK, Smyth MJ, Burrows SR et al. Coinfection with human cytomegalovirus genetic variants in transplant recipients and its impact on antiviral T cell immune reconstitution. J Virol 2016; 90: 7497– 7507 [CrossRef] [PubMed]
    [Google Scholar]
  22. Giménez E, Blanco-Lobo P, Muñoz-Cobo B, Solano C, Amat P et al. Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting. J Gen Virol 2015; 96: 2822– 2831 [CrossRef] [PubMed]
    [Google Scholar]
  23. Giménez E, Muñoz-Cobo B, Solano C, Amat P, de La Cámara R et al. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+ T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation. Transpl Infect Dis 2015; 17: 361– 370 [CrossRef] [PubMed]
    [Google Scholar]
  24. Tong Y, Pang XL, Mabilangan C, Preiksaitis JK. Determination of the biological form of human cytomegalovirus DNA in the plasma of solid-organ transplant recipients. J Infect Dis 2017; 215: 1094– 1101 [CrossRef] [PubMed]
    [Google Scholar]
  25. Cicin-Sain L, Podlech J, Messerle M, Reddehase MJ, Koszinowski UH. Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol 2005; 79: 9492– 9502 [CrossRef] [PubMed]
    [Google Scholar]
  26. Solano C, Muñoz-Cobo B, Giménez E, Remigia MJ, Amat P et al. Pre-emptive antiviral therapy for active CMV infection in adult allo-SCT patients guided by plasma CMV DNAemia quantitation using a real-time PCR assay: clinical experience at a single center. Bone Marrow Transplant 2013; 48: 1010– 1012 [CrossRef] [PubMed]
    [Google Scholar]
  27. Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011; 27: 863– 864 [CrossRef] [PubMed]
    [Google Scholar]
  28. Aronesty E. Comparison of sequencing utility programs. Open Bioinforma J 2013; 7: 1– 8 [CrossRef]
    [Google Scholar]
  29. Töpfer A, Zagordi O, Prabhakaran S, Roth V, Halperin E et al. Probabilistic inference of viral quasispecies subject to recombination. J Comput Biol 2013; 20: 113– 123 [CrossRef] [PubMed]
    [Google Scholar]
  30. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011; 27: 2194– 2200 [CrossRef] [PubMed]
    [Google Scholar]
  31. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009; 25: 1451– 1452 [CrossRef] [PubMed]
    [Google Scholar]
  32. Excoffier L, Lischer HEL. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 2010; 10: 564– 567 [CrossRef]
    [Google Scholar]
  33. Larkin MA, Blackshields G, Brown NP, Chenna R, Mcgettigan PA et al. CLUSTAL W and CLUSTAL X version 2.0. Bioinformatics 2007; 23: 2947– 2948 [CrossRef] [PubMed]
    [Google Scholar]
  34. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30: 1312– 1313 [CrossRef] [PubMed]
    [Google Scholar]
  35. Tamura K, Peterson D, Peterson N, Stecher G, Nei M et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28: 2731– 2739 [CrossRef] [PubMed]
    [Google Scholar]
  36. Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 1999; 190: 177– 182 [CrossRef] [PubMed]
    [Google Scholar]
  37. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295– 304 [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000916
Loading
/content/journal/jgv/10.1099/jgv.0.000916
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error